Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant609 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03088176 | Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma | unknown | Phase 1 | 4 | West Cancer CenterOTHER | 1 | Oct 12, 2020 | clinicaltrials |
| NCT03086174 | Tolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and Melanoma | unknown | Phase 1 | 24 | Shanghai Junshi Bioscience Co., Ltd.OTHER | 1 | Sep 30, 2020 | clinicaltrials |
| NCT04021420 | Safety and Efficacy of Sonocloud Device Combined With Nivolumab in Brain Metastases From Patients With Melanoma(SONIMEL01) | unknown | Phase 1 / Phase 2 | 21 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Aug 20, 2020 | clinicaltrials |
| NCT04072900 | A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma | unknown | Phase 1 | 30 | Xiangya Hospital of Central South UniversityOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT04357509 | The Tolerance,Pharmacokinetic Characteristics,Safety and Efficacy of ScTIL210 in the Treatment of Melanoma | unknown | Phase 1 | 32 | Peking University Cancer Hospital & InstituteOTHER | 1 | Apr 24, 2020 | clinicaltrials |
| NCT04206358 | Study to Evaluate OrienX010 in Combination With JS001 in the Treatment of Stage IV (M1c) Liver Metastasis From Melanoma | unknown | Phase 1 | 30 | Peking University Cancer Hospital & InstituteOTHER | 1 | Dec 20, 2019 | clinicaltrials |
| NCT03638206 | Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies | unknown | Phase 1 / Phase 2 | 73 | Shenzhen BinDeBio Ltd.INDUSTRY | 1 | Dec 11, 2019 | clinicaltrials |
| NCT03903458 | Tinostamustine and Nivolumab in Advanced Melanoma(ENIgMA) | unknown | Phase 1 | 21 | Markus JoergerOTHER | 1 | Apr 8, 2019 | clinicaltrials |
| NCT03353402 | Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy | unknown | Phase 1 | 40 | Sheba Medical CenterOTHER_GOV | 1 | Apr 3, 2019 | clinicaltrials |
| NCT02654821 | Study With T-cel Receptor Gene Therapy in Metastatic Melanoma(TCR) | unknown | Phase 1 / Phase 2 | 12 | The Netherlands Cancer InstituteOTHER | 1 | Nov 2, 2018 | clinicaltrials |
| NCT03050047 | A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 15 | BiocadINDUSTRY | 1 | Aug 31, 2018 | clinicaltrials |
| NCT03464032 | A Study of BCD-135 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 30 | BiocadINDUSTRY | 1 | Mar 13, 2018 | clinicaltrials |
| NCT03098160 | Immunotherapy Study of Evofosfamide in Combination With Ipilimumab | unknown | Phase 1 | 69 | Threshold PharmaceuticalsINDUSTRY | 1 | Oct 30, 2017 | clinicaltrials |
| NCT02990416 | A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma | unknown | Phase 1 / Phase 2 | 63 | Virogen Biotechnology Inc.INDUSTRY | 1 | Dec 13, 2016 | clinicaltrials |
| NCT02457650 | T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies | unknown | Phase 1 | 36 | Shenzhen Second People's HospitalOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT02759536 | In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma | unknown | Phase 1 / Phase 2 | 30 | The Third Xiangya Hospital of Central South UniversityOTHER | 1 | Jun 7, 2016 | clinicaltrials |
| NCT02202200 | Phase I-II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation and Pharmacokinetics of PD-0332991 in Patients Suffering Metastatic Melanoma(OPTIMUM) | unknown | Phase 1 / Phase 2 | 40 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 18, 2016 | clinicaltrials |
| NCT02671513 | A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients | unknown | Phase 1 | 30 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 12, 2016 | clinicaltrials |
| NCT02619058 | A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients | unknown | Phase 1 | 20 | Peking University Cancer Hospital & InstituteOTHER | 1 | Dec 4, 2015 | clinicaltrials |
| NCT02608437 | A Study Investigating SGI-110 in Combination With Ipilimumab in Unresectable or Metastatic Melanoma Patients(NIBIT-M4) | unknown | Phase 1 | 19 | Italian Network for Tumor Biotherapy FoundationOTHER | 1 | Nov 18, 2015 | clinicaltrials |
| NCT01882946 | Safety and Efficacy Study of DCVax-Direct in Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Northwest BiotherapeuticsINDUSTRY | 1 | Oct 7, 2015 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00002817 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | unknown | Phase 1 / Phase 2 | 30 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00538005 | Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma | unknown | Phase 1 / Phase 2 | 54 | San Diego Pacific Oncology & Hematology AssociatesOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00004025 | Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma | unknown | Phase 1 / Phase 2 | 36 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00010309 | Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma | unknown | Phase 1 / Phase 2 | — | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00022568 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | unknown | Phase 1 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00037037 | Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma | unknown | Phase 1 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00391300 | Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions | unknown | Phase 1 | 100 | Eastern Virginia Medical SchoolOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00003747 | Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma | unknown | Phase 1 | 30 | Mount Vernon Cancer Centre at Mount Vernon HospitalOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00016055 | Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma | unknown | Phase 1 | 18 | St. Luke's Medical CenterOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00002781 | Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma | unknown | Phase 1 | 15 | Beth Israel Deaconess Medical CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00006035 | Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma | unknown | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00017355 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | unknown | Phase 1 | — | Baylor Health Care SystemOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00126685 | Vaccine Therapy in Treating Patients With Stage IV Melanoma | unknown | Phase 1 / Phase 2 | 30 | Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum ErlangenOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT01082198 | Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes | unknown | Phase 1 / Phase 2 | 22 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01331915 | Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients(THERAVAC) | unknown | Phase 1 / Phase 2 | 23 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Oct 10, 2012 | clinicaltrials |
| NCT01614301 | Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma | unknown | Phase 1 / Phase 2 | 136 | University of RegensburgOTHER | 1 | Jun 7, 2012 | clinicaltrials |
| NCT01584115 | Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA) | unknown | Phase 1 / Phase 2 | 15 | Instituto de Investigação em ImunologiaOTHER | 1 | Apr 25, 2012 | clinicaltrials |
| NCT00409383 | Abraxane and Temodar Plus Genasense in Advanced Melanoma | unknown | Phase 1 | 28 | Genta IncorporatedINDUSTRY | 1 | Nov 7, 2011 | clinicaltrials |
| NCT00811759 | Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma | unknown | Phase 1 / Phase 2 | 58 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Oct 7, 2010 | clinicaltrials |
| NCT00701987 | Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma | unknown | Phase 1 | 12 | Advanced Life Sciences, Inc.INDUSTRY | 1 | Feb 3, 2010 | clinicaltrials |
| NCT00108875 | Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer | unknown | Phase 1 / Phase 2 | 70 | Julius-Maximilians UniversityOTHER | 1 | Jul 28, 2006 | clinicaltrials |
| NCT00111046 | Pain Relief - Tramadol Versus Ibuprofen | unknown | Phase 1 / Phase 2 | 40 | Royal Liverpool University HospitalOTHER_GOV | 1 | Nov 10, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Oct 12, 2020source: clinicaltrials